Opendata, web and dolomites

Bacticon1

BACTerial detection and CONtrol of urinary tract infection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Bacticon1 project word cloud

Explore the words cloud of the Bacticon1 project. It provides you a very rough idea of what is the project "Bacticon1" about.

revenue    channels    patient    add    hospital    impregnation    pursuing    death    biomodics    hybrid    rates    bio    biomarker    nanoparticles    prolonged    severe    monitoring    mean    547    urinary    sustainability    dominating    portfolio    markets    route    acquired    solution    time    days    fourth    infections    american    fact    delay    nano    615    care    market    die    temperature    things    incur    economic    approx    economical    feasibility    biosensor    suited    innovation    problem    search    patients    false    excessive    strategy    detection    western    marketing    stays    stream    infection    faster    tech    measuring    efficient    business    med    prototype    precise    50    biomarkers    conducting    expenses    commercialised    socio    verify    catheters    caused    place    remaining    blood    technological    option    asia    sales    possibilities    material    urological    positives    world    adjust    catheter    approval    bacticon    benchmarking    company    indicates    model   

Project "Bacticon1" data sheet

The following table provides information about the project.

Coordinator
BIOMODICS APS 

Organization address
address: STENGARDS ALLE 31 A
city: KGS LYNGBY
postcode: 2800
website: www.biomodics.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website http://www.biomodics.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOMODICS APS DK (KGS LYNGBY) coordinator 50˙000.00

Map

 Project objective

Problem Approx. 50% of all patients with severe blood stream infections die from the infections, while the remaining 50% incur excessive socio-economic expenses from prolonged hospital stays. In fact, the fourth largest cause of death in the western world is hospital and care acquired infections, most often caused by urinary catheters. Present state-of-the-art, measuring the temperature of a patient, indicates if the patient has an infection, but with approx. 2-3 days delay, and with many possibilities for false positives (increasing temperature can mean other things than infection).

Solution The innovation, the Bacticon Catheter, is a catheter impregnation technology based on a new biosensor/biomarker principle based on biomarkers, bio-nanoparticles and nano-channels in a new hybrid material, allowing for an immediate detection. The system is an add-on to existing catheters and is therefore cost efficient and face a faster route through approval procedures, providing much more precise and real-time monitoring.

Project The project has three objectives: 1: Technological feasibility study: Verify and adjust an integrated prototype 2: User feasibility study: Verify the product need by conducting a market and user study, a product innovation strategy, partner search, feasibility of concept, benchmarking with other products and a go-to-market strategy. 3: Economical feasibility study: Analyse the economical sustainability of the product

Business model The innovation is well suited to be commercialised through the sales and marketing channels of a med-tech company, which is already established in the market place, and where the Bacticon Catheter can be integrated in the existing product portfolio of such med-tech company. BioModics is pursuing this option as priority one.

Market The dominating markets are the American market with a 547 M€ urological catheter revenue and Europe with 615 M€. Increasing growth rates are expected, especially in Asia, Europe and US.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BACTICON1" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BACTICON1" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

RESHAPE (2019)

Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More